Costs and neonatal outcomes after insulin aspart compared with human insulin in pregnant women with type I diabetes

被引：0
|
作者：
Lioxd, A. C. [1 ]
Twena, N. [2 ]
Townsend, C. [3 ]
Holman, A. J. [1 ]
机构：
[1] Fourth Hurdle Consulting, London, England
[2] Novo Nordisk Ltd, Crawley, W Sussex, England
[3] Novo Nordisk AS, Virum, Denmark
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A262 / A262
页数：1
相关论文
共 50 条
  • [41] A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients
    Pala, L.
    Mannucci, E.
    Dicembrini, I.
    Rotella, C. M.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 78 (01) : 132 - 135
  • [42] THE DAILY NEED FOR INSULIN IN PREGNANT WOMEN WITH TYPE 1 DIABETES, RECEIVING INSULIN WITH INSULIN PUMP
    Valeeva, F.
    Sharipova, J.
    Alimetova, Z.
    Gaysina, L.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A114 - A114
  • [43] CONTINUOUS GLUCOSE MONITORING METRICS AND NEONATAL OUTCOMES IN PREGNANT WOMEN WITH INSULIN-TREATED DIABETES
    Citro, F.
    Nicoli, F.
    Bianchi, C.
    Aragona, M.
    Battini, L.
    Del Prato, S.
    Bertolotto, A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A58 - A58
  • [44] Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus
    Pettitt, DJ
    Kolaczynski, JW
    Ospina, P
    Jovanovic, L
    [J]. DIABETES CARE, 2003, 26 (01) : 183 - 186
  • [45] Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial
    van Bon, Arianne C.
    Bode, Bruce W.
    Sert-Langeron, Caroline
    DeVries, J. Hans
    Charpentier, Guillaume
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (06) : 607 - 614
  • [46] Pump compatibility of insulin aspart compared to insulin lispro with respect to catheter complications and dermal/subcutaneous irritations in type I diabetes patients with insulin pump therapy (CSII)
    Siegmund, T
    von Amelunxen, S
    Kaiser, M
    Schumm-Draeger, PM
    [J]. DIABETOLOGIA, 2005, 48 : A299 - A299
  • [47] GLYCEMIC CONTROL IN THE INPATIENT SETTING: INSULIN ASPART COMPARED TO HUMAN BOLUS INSULIN
    Ko, K.
    Tomor, V
    Bouchard, J. R.
    Aagren, M.
    Dubois, R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A404 - A404
  • [48] Biphasic insulin aspart vs. human insulin in adolescents with type 1 diabetes on multiple daily insulin injections
    Mortensen, H
    Kocova, M
    Teng, LY
    Keiding, J
    Bruckner, I
    Philotheou, A
    [J]. PEDIATRIC DIABETES, 2006, 7 (01) : 4 - 10
  • [49] Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes
    Dardano, Angela
    Bianchi, Cristina
    Del Prato, Stefano
    Miccoli, Roberto
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 465 - 475
  • [50] Maternal glycemic control and hypoglycomia in type 1 diabetic pregnancy - A randomized trial of insulin aspart versus human insulin in 322 pregnant women
    Mathiesen, Elisabeth R.
    Kinsley, Brendan
    Amiel, Stephanie A.
    Heller, Simon
    McCance, David
    Duran, Santiago
    Bellaire, Shannon
    Raben, Anne
    [J]. DIABETES CARE, 2007, 30 (04) : 771 - 776
12345